BioNTech publishes 2025 sustainability report highlighting 50% COVID-19 vaccine market share

Reuters03-24
BioNTech publishes 2025 sustainability report highlighting 50% COVID-19 vaccine market share
  • BioNTech’s sustainability report describes a governance structure in which the Management Board holds overall responsibility for corporate sustainability and responsibility, supported by a CSR department reporting to Chief Operating Officer Sierk Poetting.
  • The company says it launched a company-wide integration project to improve sustainability data quality, processes, and architecture, with rollout planned from 2026.
  • BioNTech reports a COVID-19 vaccine market share of over 50% during the fall 2025 vaccination season.
  • The report states BioNTech shipped more than 5 billion COVID-19 vaccine doses to more than 180 countries and territories.
  • BioNTech reports total donations of EUR 170,025 and says it established a cross-functional Corporate Funding Committee to evaluate charitable donations and corporate sponsorships.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief on March 24, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment